Antiepileptic drugs with nootropic effect is the best choice if you need a comprehensive treatment for comorbid disorders


  • Yu.I. Goransky Odessa National Medical University, Odesa, Ukraine, Ukraine
  • V.M. Hertsev Odessa National Medical University, Odesa, Ukraine, Ukraine
  • M.Yu. Serhieieva Odessa National Medical University, Odesa, Ukraine, Ukraine



epilepsy, antiepileptic drugs, cognitive functions, qua-lity of life, side effects, levetiracetam


The article presents the results of a review devoted to the search for optimal methods of treatment in patients with epilepsy with concomitant cognitive impairments. It has been established that antiepileptic drugs with a nootropic effect are the most optimal choice in terms of compliance with the therapy, as well as reducing the frequency of side effects in the case of monotherapy in comparison with the combined use of nootropics and antiepileptic drugs. Levetiracetam is one of the drugs of choice with proven beneficial effects on cognitive function in patients with epilepsy. Due to high safety profile, it can be recommended for use in elderly patients with epilepsy, including for the termination of status epilepticus, and can also be used in cases of combination of Alzheimer’s disease with epilepsy. A promising direction for further researches is to study the possibilities of using levetiracetam in traumatic injuries of the nervous system.


Дзяк Л.А., Зенков Л.Р., Кириченко А.Г. Эпилепсия. Киев: Книга-плюс, 2001. 168 с.

Бадалян О.Л., Бурд С.Г., Савенков А.А., Тертышник О.Ю., Юцкова Е.В., Тарарина Л.А. Применение Фенотропила в лечении неврологических заболеваний. Русский медицинский журнал. М. 2006. 14(16). 1222-1228.

Бадалян О.Л., Савенков А.А., Авакян Г.Н., Юцкова Е.В. Возможности применения ноотропных препаратов в комплексном лечении эпилепсии. Эпилепсия и пароксизмальные состояния. 2013. № 2. URL:

Карлов В.А. и др. Эпилепсия у детей и взрослых, женщин и мужчин. Руководство для врачей. Москва, 2010. 720 с.

Mattes A., Schneble H. Epilepsien. Diagnostik und Terapie fur Klinik und Praxis. New York: Tieme Verlag, 1992.

Li J.J., Corey E.J. Drug Discovery: Practices, Processes, and Perspectives. John Wiley & Sons, 2013. Р. 276. ISBN 9781118354469.

Giurgea C. Vers une pharmacologie de l’activit? integrative du cerveau. Tentative du concept nootrope en psychopharmacologie [Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology]. Actual Pharmacol. (Paris). 1972. 25. 115-56. French. PMID: 4541214.

Воронина Т.А., Середенин С.Б. Ноотропные препараты, достижения и новые проблемы. Экспериментальная и клиническая фармакология. 1998. Т. 61. № 4. С. 3-9.

Koskiniemi M., Van Vleymen B., Hakamies L. et al Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo Journal of Neurology, Neurosurgery & Psychiatry 1998. 64. 344-348.

Pulliainen V., Jokelainen M. Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients. Acta Neurol. Scand. 1994. 89. 81-86.

Meador K.J., Loring D.W., Allen M.E., Zamrini E.Y., Moore E.E., Abney O.L., et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology. 1991. 41. 1537-1540.

Meador K.J., Loring D.W., Moore E.E., Thompson W.O., Nichols M.E., Oberzan R.E. et al. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in adults subjects. Neurology. 1995. 45. 1494-1499.

Tonekaboni S.H., Beyraghi N., Tahbaz H.S., Bahrey-nian S.A., Aghamohammadpoor M. Neurocognitive effects of phenobarbital discontinuation in epileptic children. Epilepsy Behav. 2006. 8. 145-148.

Park S.P., Kwon S.H. Cognitive effects of antiepileptic drugs. J. Clin. Neurol. 2008. 4(3). 99-106. doi: 10.3988/jcn.2008.4.3.99.

Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., Fuks B. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc. Natl. Acad. Sci USA. 2004 Jun 29. 101(26). 9861-6. doi: 10.1073/pnas.0308208101. Epub2004 Jun 21. PMID: 15210974; PMCID: PMC470764.

National Center for Biotechnology Information. PubChem Compound Summary for CID 5284583, Levetiracetam. Retrieved August 28, 2021.

Physicians Desk Reference. 61st ed. Montvale, NJ: Thomson PDR, 2007. Р. 3315.

Lopez-Gongora M., Martinez-Domeno A., Garcia C. et al. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. Epileptic Disord. 2008. 10. 297-305.

Mbizvo G.K., Dixon P., Hutton J.L. et al. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database Syst Rev. 2012. CD001901.

Koo D.L., Hwang K.J., Kim D. et al. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients. Eur. Neurol. 2013. 70. 88-94.

Zhou S., Zhan Q., Wu X. Effect of Levetiracetam on Cognitive Function and Clonic Seizure Frequency in Children with Epilepsy. Curr. Mol. Med. 2019. 19(9). 699-703. doi: 10.2174/1566524019666190729113321. PMID: 31362674.

Zhao L., Wu Y.P., Qi J.L., Liu Y.Q., Zhang K., Li W.L. Efficacy of levetiracetam compared with phenytoin in prevention of seizures in brain injured patients: A meta-analysis. Medicine (Baltimore). 2018. 97(48). e13247. doi:10.1097/MD.0000000000013247.

Akter N., Rahman M.M., Akhter S., Fatema K. A Randomized Controlled Trial of Phenobarbital and Levetiracetam in Childhood Epilepsy. Mymensingh Med. J. 2018 Oct. 27(4). 776-784. PMID: 30487494.

El Sabaa R.M., Hamdi E., Hamdy N.A., Sarhan H.A. Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy. Neuropsychiatr. Dis. Treat. 2020. 16. 1945-1953. Published 2020 Aug 11. doi:10.2147/NDT.S256117.

Liu J., Wang L.-N. Treatment of epilepsy for people with Alzheimer’s disease. Cochrane Database of Systematic Reviews. 2021, Issue 5. Art. No.: CD011922. DOI: 10.1002/14651858.CD011922.pub4. Accessed 26 July 2021.

Tombini M., Assenza G., Ricci L., et al. Temporal Lobe Epilepsy and Alzheimer’s Disease: From Preclinical to Clinical Evidence of a Strong Association. J Alzheimer’s Dis Rep. 2021. 5(1). 243-261. Published 2021 Apr 6. doi:10.3233/ADR-200286.

Fattouch J., Di Bonaventura C., Casciato S., Bonini F., Petrucci S., Lapenta L., Manfredi M., Prencipe M., Giallonardo A.T. Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly. Acta Neurol/ Scand. 2010 Jun. 121(6). 418-21. doi: 10.1111/j.1600-0404.2010.01351.x. PMID: 20578996.

Lima R., Gomes E.D., Cibrão J.R. et al. Levetiracetam treatment leads to functional recovery after thoracic or cervical injuries of the spinal cord. NPJ Regen. Med. 6. 11 (2021).

Carney N., Totten A.M., O’Reilly C. et al. Guidelines for the management of severe traumatic brain injury. Fourth edition. Neurosurgery. 2016. 80. 6-15.

Caballero G.C., Hughes D.W., Maxwell P.R., Green K., Gamboa C.D., Barthol C.A. Retrospective analysis of levetiracetam compared to phenytoin for seizure prophylaxis in adults with traumatic brain injury. Hosp. Pharm. 2013. 48. 757-761.

Temkin N.R., Dikmen S.S., Winn HR. Management of Head Injury. Philadelphia, PA: W.B. Saunders, 1991. Posttraumatic seizures. Р. 425-435.

Inaba K., Menaker J., Branco B.C. et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J. Trauma Acute Care Surg. 2013. 74. 766-773.

Guidelines for the management of severe traumatic brain injury. XIII. Antiseizure prophylaxis. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons. J. Neurotrauma. 2007. 24. 83-86.

DJohn J., Ibrahim R., Patel P., DeHoff K., Kolbe N. Admi-nistration of Levetiracetam in Traumatic Brain Injury: Is it Warran-ted? Cureus. 2020. 12(7). e9117. Published 2020 Jul 10. doi:10.7759/cureus.9117.

Hazama A., Ziechmann R., Arul M., Krishnamurthy S., Galgano M., Chin L.S. The Effect of Keppra Prophylaxis on the Incidence of Early Onset, Post-traumatic Brain Injury Seizures. Cureus. 2018. 10(5). e2674. Published 2018 May 23. doi:10.7759/cureus.2674.





To practicing Neurologist